Job Description:
Headquartered in San Diego, California, Illumina (NASDAQ: ILMN), is a leading developer, manufacturer, and marketer of next generation life science tools and integrated systems for large-scale analysis of genetic variation and biological function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With the innovative advances in our sequencing technologies, we are rapidly impacting the clinical market in areas such as reproductive health and oncology. The expanding Illumina oncology portfolio of next- generation sequencing NGS and microarray technologies is revolutionizing cancer genomics research. Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.
lllumina has experienced phenomenal growth from $10 million in revenues in 2002 to over $1.4 billion in 2013. Forbes named Illumina #1 on the 2009 list of 25 Fastest-Growing Technology Companies in the United States, the second time over a three year period that Forbes ranked Illumina #1 on its list of rapidly growing technology companies. Illumina was also named #1 smartest company in the world as part of MIT’s 2014 Technology Review. As of August 2014, the company had a $24 billion market capitalization.
Located within the Enterprise Informatics Business Unit at Illumina, this position leads the development of bioinformatics methods for applications in Clinical Genetics. The director will work with informatics colleagues to develop best-in class tools for the generation, integration, interpretation, and visualization of molecular data for translational medicine and clinical genetics practice. S/he will provide scientific leadership and direction and provide strategic input into informatics product development activities for medical genetics, including rare, undiagnosed and common complex diseases. S/he will provide major input into the creation, validation and testing of clinical next generation sequencing assays and tools from a methods and software perspective.
The Associate Director will partner with internal R&D, Clinical, and Business Units and external clients to develop bioinformatics and data science methods as the groups develop clinical assays. The director will lead the evaluation of internal and external methods and establish presence and leadership with industry and academic partners. The director will build a team focusing on utilizing data-driven methods and analytics to drive implementation of new bioinformatics methods
Responsibilities:
- Develop and maintain high level software architecture for a cloud platform
- Create and communicate software architecture roadmap
- Work with software application teams to ensure alignment of architecture to user requirements
- Ensure adherence of development efforts within EIBU to the software architecture
- Maintain awareness of industry trends and evaluate applicability of new software technologies to platform development efforts
Requirements:
- Clinical molecular pathology or molecular genetics experience preferred.
- Ability to work with clinical partners in the specification of methods and development of tools for interpretation and reporting of next generation sequencing findings is required.
- Familiarity with the scientific fields relevant to molecular genetics required including molecular biology, genetics and pathology with strong knowledge/competence in at least one is also required. Strong knowledge of computational biology and next generation sequencing methods and applications is required.
- Laboratory experience in molecular biology or genetics in a research or clinical setting required.
- Experience in test development, validation, and implementation is preferred.
- Experience in translational research and technology transfer and knowledge of regulatory compliance and quality systems in patient care settings preferred.
- Strong understanding of software validation and operations and the ability to review clinical cases is required.
- Successful candidates will have an in depth understanding of at least one area of clinical medicine.
- Demonstrated skill in project management required, as is a strong analytical ability to evaluate and ensure accuracy of data related to quality control and continuous process improvement.
- Excellent communication and presentation skills, the ability to work in a multidisciplinary and environment and proven ability to lead and manage teams required
Education:
Candidates must be a M.D. and/or Ph.D. with clinical next generation sequencing experience and strong knowledge of clinical genetics in practice. EOE/Minorities/Females/Veterans/Disabled
Additional Info:
[Click Here to Access the Original Job Post]
Headquartered in San Diego, California, Illumina (NASDAQ: ILMN), is a leading developer, manufacturer, and marketer of next generation life science tools and integrated systems for large-scale analysis of genetic variation and biological function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With the innovative advances in our sequencing technologies, we are rapidly impacting the clinical market in areas such as reproductive health and oncology. The expanding Illumina oncology portfolio of next- generation sequencing NGS and microarray technologies is revolutionizing cancer genomics research. Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.
lllumina has experienced phenomenal growth from $10 million in revenues in 2002 to over $1.4 billion in 2013. Forbes named Illumina #1 on the 2009 list of 25 Fastest-Growing Technology Companies in the United States, the second time over a three year period that Forbes ranked Illumina #1 on its list of rapidly growing technology companies. Illumina was also named #1 smartest company in the world as part of MIT’s 2014 Technology Review. As of August 2014, the company had a $24 billion market capitalization.
Located within the Enterprise Informatics Business Unit at Illumina, this position leads the development of bioinformatics methods for applications in Clinical Genetics. The director will work with informatics colleagues to develop best-in class tools for the generation, integration, interpretation, and visualization of molecular data for translational medicine and clinical genetics practice. S/he will provide scientific leadership and direction and provide strategic input into informatics product development activities for medical genetics, including rare, undiagnosed and common complex diseases. S/he will provide major input into the creation, validation and testing of clinical next generation sequencing assays and tools from a methods and software perspective.
The Associate Director will partner with internal R&D, Clinical, and Business Units and external clients to develop bioinformatics and data science methods as the groups develop clinical assays. The director will lead the evaluation of internal and external methods and establish presence and leadership with industry and academic partners. The director will build a team focusing on utilizing data-driven methods and analytics to drive implementation of new bioinformatics methods
Responsibilities:
- Develop and maintain high level software architecture for a cloud platform
- Create and communicate software architecture roadmap
- Work with software application teams to ensure alignment of architecture to user requirements
- Ensure adherence of development efforts within EIBU to the software architecture
- Maintain awareness of industry trends and evaluate applicability of new software technologies to platform development efforts
Requirements:
- Clinical molecular pathology or molecular genetics experience preferred.
- Ability to work with clinical partners in the specification of methods and development of tools for interpretation and reporting of next generation sequencing findings is required.
- Familiarity with the scientific fields relevant to molecular genetics required including molecular biology, genetics and pathology with strong knowledge/competence in at least one is also required. Strong knowledge of computational biology and next generation sequencing methods and applications is required.
- Laboratory experience in molecular biology or genetics in a research or clinical setting required.
- Experience in test development, validation, and implementation is preferred.
- Experience in translational research and technology transfer and knowledge of regulatory compliance and quality systems in patient care settings preferred.
- Strong understanding of software validation and operations and the ability to review clinical cases is required.
- Successful candidates will have an in depth understanding of at least one area of clinical medicine.
- Demonstrated skill in project management required, as is a strong analytical ability to evaluate and ensure accuracy of data related to quality control and continuous process improvement.
- Excellent communication and presentation skills, the ability to work in a multidisciplinary and environment and proven ability to lead and manage teams required
Education:
Candidates must be a M.D. and/or Ph.D. with clinical next generation sequencing experience and strong knowledge of clinical genetics in practice. EOE/Minorities/Females/Veterans/Disabled
Skills :
Areas :
Additional Info:
[Click Here to Access the Original Job Post]